These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

25 related articles for article (PubMed ID: 35392481)

  • 1. Effectiveness of and Inequalities in COVID-19 Epidemic Control Strategies in Hungary: A Nationwide Cross-Sectional Study.
    Wasnik RN; Vincze F; Földvári A; Pálinkás A; Sándor J
    Healthcare (Basel); 2023 Apr; 11(9):. PubMed ID: 37174762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 Testing Unit Munich: Impact of Public Health and Safety Measures on Patient Characteristics and Test Results, January to September 2020.
    Hohl HT; Heumann C; Rothe C; Hoelscher M; Janke C; Froeschl G
    Front Public Health; 2022; 10():856189. PubMed ID: 35392481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient characteristics and testing over COVID-19 waves 1 and 2 from the first German COVID-19 testing unit in Munich, Germany.
    Srinivasan H; Hohl HT; Heumann C; Froeschl G
    BMC Infect Dis; 2023 Feb; 23(1):111. PubMed ID: 36823537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroprevalence of Unidentified SARS-CoV-2 Infection in Hong Kong During 3 Pandemic Waves.
    Boon SS; Wong MCS; Ng RWY; Leung DTM; Chen Z; Lai CKC; Ho WCS; Huang J; Wong BKC; Fung KSC; Chan PKS
    JAMA Netw Open; 2021 Nov; 4(11):e2132923. PubMed ID: 34779848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early trends for SARS-CoV-2 infection in central and north Texas and impact on other circulating respiratory viruses.
    Mutnal MB; Arroliga AC; Walker K; Mohammad A; Brigmon MM; Beaver RM; Midturi JK; Rao A
    J Med Virol; 2020 Oct; 92(10):2130-2138. PubMed ID: 32410236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective public health measures to mitigate the spread of COVID-19: a systematic review.
    Ayouni I; Maatoug J; Dhouib W; Zammit N; Fredj SB; Ghammam R; Ghannem H
    BMC Public Health; 2021 May; 21(1):1015. PubMed ID: 34051769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and Risk Factors of Infection in the Representative COVID-19 Cohort Munich.
    Pritsch M; Radon K; Bakuli A; Le Gleut R; Olbrich L; Guggenbüehl Noller JM; Saathoff E; Castelletti N; Garí M; Pütz P; Schälte Y; Frahnow T; Wölfel R; Rothe C; Pletschette M; Metaxa D; Forster F; Thiel V; Rieß F; Diefenbach MN; Fröschl G; Bruger J; Winter S; Frese J; Puchinger K; Brand I; Kroidl I; Hasenauer J; Fuchs C; Wieser A; Hoelscher M; On Behalf Of The KoCo Study Group
    Int J Environ Res Public Health; 2021 Mar; 18(7):. PubMed ID: 33808249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of seroprevalence of SARS-CoV-2 infections with cumulative and imputed COVID-19 cases: Systematic review.
    Byambasuren O; Dobler CC; Bell K; Rojas DP; Clark J; McLaws ML; Glasziou P
    PLoS One; 2021; 16(4):e0248946. PubMed ID: 33798211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Robust estimation of diagnostic rate and real incidence of COVID-19 for European policymakers.
    Català M; Pino D; Marchena M; Palacios P; Urdiales T; Cardona PJ; Alonso S; López-Codina D; Prats C; Alvarez-Lacalle E
    PLoS One; 2021; 16(1):e0243701. PubMed ID: 33411737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Model predictive control to mitigate the COVID-19 outbreak in a multi-region scenario.
    Carli R; Cavone G; Epicoco N; Scarabaggio P; Dotoli M
    Annu Rev Control; 2020; 50():373-393. PubMed ID: 33024411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis.
    Chu DK; Akl EA; Duda S; Solo K; Yaacoub S; Schünemann HJ;
    Lancet; 2020 Jun; 395(10242):1973-1987. PubMed ID: 32497510
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.